Cryo-Cell International (NYSEAMERICAN:CCEL) Stock Price Down 10.2% – Time to Sell?

Cryo-Cell International Inc. (NYSEAMERICAN:CCEL)’s stock price traded down 10.2% during trading on Friday. The company traded as low as $4.34 and last traded at $4.85. 14,208 shares were traded during trading, an increase of 68% from the average daily volume of 8,440 shares. The stock had previously closed at $5.40.

Cryo-Cell International Price Performance

The company has a market cap of $39.09 million, a P/E ratio of -21.09 and a beta of 0.45. The company’s 50-day moving average is $4.47 and its two-hundred day moving average is $3.76.

Cryo-Cell International (NYSEAMERICAN:CCEL) last released its quarterly earnings data on Friday, October 9th. The company reported $0.16 earnings per share (EPS) for the quarter. The business had revenue of $7.82 million during the quarter.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Cryo-Cell International stock. Susquehanna International Group LLP lifted its holdings in shares of Cryo-Cell International Inc. (NYSEAMERICAN:CCEL) by 40.4% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 14,064 shares of the company’s stock after buying an additional 4,046 shares during the period. Susquehanna International Group LLP owned approximately 0.17% of Cryo-Cell International worth $45,000 at the end of the most recent reporting period. 10.44% of the stock is currently owned by institutional investors and hedge funds.

Cryo-Cell International Company Profile

Cryo-Cell International, Inc. is a biotechnology and healthcare services company that provides stem cell collection, processing and long-term cryogenic storage. The company primarily focuses on preserving umbilical cord blood and cord tissue, which contain stem cells that may be used in certain medical treatments and regenerative medicine applications. Its services are marketed primarily to expectant parents and families through private biological material banking programs. Cryo-Cell provides collection kits, coordination with healthcare professionals, laboratory processing and secure storage services.